Picture of Dr Martens logo

DOCS Dr Martens News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMid CapNeutral

REG - Dr. Martens PLC - Block listing Interim Review

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250602:nRSB0648La&default-theme=true

RNS Number : 0648L  Dr. Martens PLC  02 June 2025

Dr. Martens plc

('Dr. Martens', 'the Company')

BLOCK LISTING SIX MONTHLY RETURN

 

 

Date: 2 JUNE 2025

 

 

 Name of applicant:                                                                DR. MARTENS PLC
 Name of scheme:                                                                   DR. MARTENS PLC'S EMPLOYEE SHARE PLANS
 Period of return:                        From:                                    1 DECEMBER 2024  To:            31 MAY 2025
 Balance of unallotted securities under scheme(s) from previous return:            1,703,276 SHARES
 Plus:  The amount by which the block scheme(s) has been increased since the       15,000,000 SHARES
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         2,102,229 SHARES
 (see UKLR 20.6.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        14,601,047 SHARES

 

 Name of contact:              PAUL ROLLING
 Telephone number of contact:  +447584243562

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRSSDFDEEISESM

Recent news on Dr Martens

See all news